CME Group Inc
NASDAQ:CME
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
225.82
289.3849
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
CME
stock under the Base Case scenario is
156.61
USD.
Compared to the current market price of 273.55 USD,
CME Group Inc
is
Overvalued by 43%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for CME Group Inc.
| US |
|
S&P Global Inc
NYSE:SPGI
|
|
| US |
|
Intercontinental Exchange Inc
NYSE:ICE
|
|
| US |
|
Moody's Corp
NYSE:MCO
|
|
| US |
|
Coinbase Global Inc
NASDAQ:COIN
|
|
| HK |
|
Hong Kong Exchanges and Clearing Ltd
HKEX:388
|
|
| UK |
|
London Stock Exchange Group PLC
LSE:LSEG
|
|
| US |
|
Nasdaq Inc
NASDAQ:NDAQ
|
|
| CN |
|
East Money Information Co Ltd
SZSE:300059
|
|
| DE |
|
Deutsche Boerse AG
XETRA:DB1
|
|
| US |
|
MSCI Inc
NYSE:MSCI
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
CME Group’s reliance on high trading volumes leaves it vulnerable to declining market volatility or prolonged stretches of muted economic activity, which could significantly reduce transaction-based revenue streams and compress margins.
Intensifying competition from rival exchanges and over-the-counter platforms offering similar or more flexible products could erode CME’s market share, leading to reduced pricing power and lower trading fees over time.
Potential regulatory changes that mandate alternative clearing arrangements or limit CME Group’s cross-margining advantages could undermine its clearing monopoly, increasing compliance costs and weakening its competitive moat.
CME Group’s diversified product mix—ranging from interest rate futures to agricultural and energy contracts—positions the exchange to capitalize on heightened hedging demand across multiple asset classes during market volatility.
The firm’s robust technology infrastructure and vertical integration of clearing services provide cost efficiencies and heighten customer stickiness, reinforcing its ability to sustain high operating margins and generate resilient cash flows.
Strategic partnerships and international expansion efforts, particularly in Asia, open new channels for growth as more global market participants seek sophisticated hedging instruments and derivative products.
Revenue & Expenses Breakdown
CME Group Inc
Balance Sheet Decomposition
CME Group Inc
| Current Assets | 152.8B |
| Cash & Short-Term Investments | 2.6B |
| Receivables | 642.9m |
| Other Current Assets | 149.6B |
| Non-Current Assets | 34.3B |
| PP&E | 355.2m |
| Intangibles | 30.4B |
| Other Non-Current Assets | 3.6B |
| Current Liabilities | 149.6B |
| Accounts Payable | 74.9m |
| Other Current Liabilities | 149.5B |
| Non-Current Liabilities | 9.4B |
| Long-Term Debt | 3.4B |
| Other Non-Current Liabilities | 5.9B |
Free Cash Flow Analysis
CME Group Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
CME Group Inc
|
Revenue
|
11.3B
USD
|
|
Operating Expenses
|
-2.2B
USD
|
|
Operating Income
|
9.1B
USD
|
|
Other Expenses
|
-5.3B
USD
|
|
Net Income
|
3.7B
USD
|
CME Profitability Score
Profitability Due Diligence
CME Group Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
CME Group Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
CME Solvency Score
Solvency Due Diligence
CME Group Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
CME Group Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CME Price Targets Summary
CME Group Inc
According to Wall Street analysts, the average 1-year price target for
CME
is 289.08 USD
with a low forecast of 203.01 USD and a high forecast of 329.7 USD.
Dividends
Current shareholder yield for
CME is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CME
stock under the Base Case scenario is
156.61
USD.
Compared to the current market price of 273.55 USD,
CME Group Inc
is
Overvalued by 43%.